Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$2.34 Mil
% of Total Estimate Gain
19.51%

Cormorant Asset Management, LP's ArriVent BioPharma Inc Holding Summary

As of 2025-03-31, Cormorant Asset Management, LP held - shares of ArriVent BioPharma Inc(AVBP), totaling N/A. This investment constitutes 0% of their stock portfolio, and Cormorant Asset Management, LP now holds 0% of the outstanding ArriVent BioPharma Inc(AVBP) stock.

The initial trade took place in 2024Q1. And since then Cormorant Asset Management, LP has made 2 purchases of AVBP, at an average price of $20.47, for a total of 585,462.00 shares. In addition, there have been 1 sales at an average price of $24.47 for 585,462.00 shares. Based on historical transaction data and AVBP's current price of $22.05, Cormorant Asset Management, LP's estimated gain on his AVBP holdings is $2.34 Mil, reflecting a 19.51% gain to date.

Cormorant Asset Management, LP AVBP ($22.05) Holding Chart

Cormorant Asset Management, LP AVBP ($22.05) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1